Trial record 1 of 4 for:    stanford SCID
Previous Study | Return to List | Next Study

AMG191 Conditioning/CD34+CD90 Stem Cell Transplant Study for SCID Patients

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT02963064
Recruitment Status : Recruiting
First Posted : November 15, 2016
Last Update Posted : November 15, 2016
California Institute for Regenerative Medicine
Information provided by (Responsible Party):
Judith Anne Shizuru, Stanford University

No Study Results Posted on for this Study
  Recruitment Status : Recruiting
  Estimated Primary Completion Date : August 2020
  Estimated Study Completion Date : August 2020